[Form 4] BioSig Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Streamex Corp. filed a Form 4 reporting an equity grant to its Chief Financial Officer. On 11/18/2025, the CFO received 60,000 shares of Streamex common stock as an acquired (A) transaction at a stated price of $0 per share under the company’s 2023 Equity Incentive Plan, described as a restricted stock award.

The award was granted based on a closing market price of $4.14 per share on the grant date and is scheduled to vest in full on the one-year anniversary of that date. Following this grant, the reporting person beneficially owned a total of 295,000 shares of Streamex common stock, held directly. No derivative securities transactions were reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Groenewald Ferdinand

(Last) (First) (Middle)

C/O STREAMEX CORP.

2431 ALOMA AVE STE 243

(Street)

WINTER PARK FL 32792

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Streamex Corp. [ STEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		60,000	A	$0(1)	295,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant.

	/s/ Ferdinand Groenewald	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Streamex Corp. (STEX) report in this Form 4 filing?

The filing reports that Streamex Corp.’s Chief Financial Officer received a restricted stock award of 60,000 shares of common stock on 11/18/2025 under the company’s 2023 Equity Incentive Plan.

What are the key terms of the restricted stock granted to the Streamex CFO?

The CFO received 60,000 restricted shares based on a closing price of $4.14 per share on 11/18/2025. The shares vest in full on the one-year anniversary of the grant date.

How many Streamex (STEX) shares does the reporting person own after this transaction?

After the reported transaction, the reporting person beneficially owned 295,000 shares of Streamex common stock, held with direct ownership.

Was there any cash paid for the Streamex restricted stock in this Form 4?

The transaction table shows the 60,000 shares of common stock were acquired with a reported price of $0 per share, consistent with a restricted stock grant under an equity incentive plan.

Under which plan was the Streamex CFO’s equity award granted?

The restricted stock award was granted under Streamex Corp.’s 2023 Equity Incentive Plan, as noted in the explanation of responses.

When will the Streamex CFO’s restricted stock vest?

The shares vest in full on the one-year anniversary of the grant date of November 18, 2025, as stated in the explanation of responses.